Literature DB >> 17922221

A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.

Susan Yount1, Marcy List, Hongyan Du, Kathleen Yost, Rita Bode, Bruce Brockstein, Athanassios Argiris, Everett Vokes, Ezra E W Cohen, Bruce Campbell, Veronica Valenzuela, Jacquelyn George, Robyn Egan, Jessica Chen, David Meddis, David Cella.   

Abstract

OBJECTIVE: To evaluate the impact of administration context (embedded versus stand-alone) on the reliability and validity of the FACT Head and Neck Symptom Index (FHNSI).
METHODS: Ninety-eight patients with head and neck cancer were randomized to one of two assessment conditions to evaluate the FHNSI's context (items administered embedded within the FACT-H&N or as stand-alone scale) and order of administration in the battery.
RESULTS: Planned comparisons on the item and scale levels revealed no systematic order or context differences. The embedded and stand-alone versions of the FHNSI showed high internal consistency (Cronbach's alpha 0.79-0.87). Correlations were high between the FHNSI versions and the physical and functional well-being scales of the FACT-H&amp;N (0.70-0.84) and measures of pain intensity (-0.73, -0.74) and depression (-0.71, -0.74); moderate to large with the Performance Status Scale for Head and Neck subscales (PSS-HN; 0.46-0.71); and low with an anxiety measure (0.30, 0.34). Both FHNSI versions differentiated patients grouped by performance status (p < .0001, p < .0001) and global rating of change (p < .0001, p < 0.01). The FHNSI's minimally important difference range was 3-4 points.
CONCLUSION: The FHNSI is a reliable and valid symptom index, which can be administered alone or scored using items embedded within the FACT-H&amp;N.

Entities:  

Mesh:

Year:  2007        PMID: 17922221     DOI: 10.1007/s11136-007-9270-9

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  43 in total

Review 1.  Mode of questionnaire administration can have serious effects on data quality.

Authors:  Ann Bowling
Journal:  J Public Health (Oxf)       Date:  2005-05-03       Impact factor: 2.341

2.  Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.

Authors:  Richard P McQuellon; Howard T Thaler; David Cella; David H Moore
Journal:  Gynecol Oncol       Date:  2006-01-10       Impact factor: 5.482

3.  Prevention of wound complications following salvage laryngectomy using free vascularized tissue.

Authors:  Kevin Fung; Theodoros N Teknos; Curtis D Vandenberg; Teresa H Lyden; Carol R Bradford; Norman D Hogikyan; Jennifer Kim; Mark E P Prince; Gregory T Wolf; Douglas B Chepeha
Journal:  Head Neck       Date:  2007-05       Impact factor: 3.147

4.  The use of quality of life data in clinical practice.

Authors:  J Morris; D Perez; B McNoe
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

5.  Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer.

Authors:  C Doyle; M Crump; M Pintilie; A M Oza
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

6.  Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.

Authors:  Joel B Epstein; Jennifer L Beaumont; Clement K Gwede; Barbara Murphy; Adam S Garden; Ruby Meredith; Quynh-Thu Le; David Brizel; John Isitt; David Cella
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

7.  Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).

Authors:  David Cella; Susan Yount; Hongyan Du; Rahul Dhanda; Kathleen Gondek; Katie Langefeld; Jacquelyn George; William P Bro; Celeste Kelly; Ronald Bukowski
Journal:  J Support Oncol       Date:  2006-04

8.  Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment.

Authors:  V T Chang; S S Hwang; M Feuerman; B S Kasimis
Journal:  Cancer       Date:  2000-03-01       Impact factor: 6.860

9.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

10.  Screening for depression in head and neck cancer.

Authors:  Mark R Katz; Neil Kopek; John Waldron; Gerald M Devins; George Tomlinson
Journal:  Psychooncology       Date:  2004-04       Impact factor: 3.894

View more
  7 in total

1.  The ENHANCES study: a randomised controlled trial of a nurse-led survivorship intervention for patients treated for head and neck cancer.

Authors:  Jane Turner; Patsy Yates; Lizbeth Kenny; Louisa G Gordon; Bryan Burmeister; Brett G M Hughes; Alexandra L McCarthy; Chris Perry; Raymond J Chan; Alana Paviour; Helen Skerman; Martin Batstone; Lisa Mackenzie
Journal:  Support Care Cancer       Date:  2019-04-02       Impact factor: 3.603

2.  Effects of patient-reported outcome assessment order.

Authors:  Paul J Novotny; Amylou C Dueck; Daniel Satele; Marlene H Frost; Timothy J Beebe; Kathleen J Yost; Minji K Lee; David T Eton; Susan Yount; David Cella; Tito R Mendoza; Charles S Cleeland; Victoria Blinder; Ethan Basch; Jeff A Sloan
Journal:  Clin Trials       Date:  2022-01-28       Impact factor: 2.599

3.  Longitudinal comparison of three depression measures in adult cancer patients.

Authors:  Shelley A Johns; Kurt Kroenke; Erin E Krebs; Dale E Theobald; Jingwei Wu; Wanzhu Tu
Journal:  J Pain Symptom Manage       Date:  2012-08-22       Impact factor: 3.612

Review 4.  Quality of Life in Patients with Advanced Cancer Using the Functional Assessment of Cancer Therapy-General Assessment Tool: A Literature Review.

Authors:  Marko Popovic; Nicholas Lao; Gillian Bedard; Liang Zeng; Liying Zhang; David Cella; Jennifer L Beaumont; Nicholas Chiu; Leonard Chiu; Henry Lam; Michael Poon; Ronald Chow; Edward Chow
Journal:  World J Oncol       Date:  2013-03-06

5.  Optimizing brief, focused assessment of priority symptoms and concerns in recurrent and/or metastatic squamous cell carcinoma of the head and neck: Content validation of the Functional Assessment of Cancer Therapy/National Comprehensive Cancer Network Head and Neck Symptom Index-10 (FHNSI-10).

Authors:  Sara Shaunfield; Susan E Yount; Lara Boyken; Mark Agulnik; Sandeep Samant; David Cella
Journal:  Health Sci Rep       Date:  2021-10-19

6.  Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study.

Authors:  Brittany Barber; Jace Dergousoff; Margaret Nesbitt; Nicholas Mitchell; Jeffrey Harris; Daniel O'Connell; David Côté; Vincent Biron; Hadi Seikaly
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-09-18

7.  Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302).

Authors:  Laura B Oswald; Ju-Whei Lee; Athanassios Argiris; Kimberly A Webster; Arlene A Forastiere; David Cella
Journal:  Cancer Med       Date:  2020-10-10       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.